Corbus Pharmaceuticals Holdings, Inc. (CRBP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 108.4M |
| Enterprise Value | 81.54M |
| P/E Ratio | -0.63 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.98 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.44 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.95 |
| Return On Equity | -1.01 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -78.3M |
| Net Income | -78.54M |
| Diluted EPS | -5.9 |
| Total Cash | 115.34M |
| Total Cash/Share | 5.53 |
| Total Debt | 3.91M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 3.4 |
| Book Value Per Share | 4.07 |
| 52-Week Change | -64.25 |
| 52-Week High | 12.88 |
| 52-Week Low | 2.81 |
| Moving Average 50 Days | 5.99 |
| Moving Average 200 Days | 8.41 |
| Average Volume | 1.07M |
| Shares Outstanding | 19.34M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | February 14, 2023 |